An expert pharmacist discusses how pharmacists play a central role in recognizing, managing, and supporting patients with tardive dyskinesia through early identification, optimized therapy selection, and interdisciplinary collaboration to improve outcomes and adherence.
This content is a production of Drug Topics; this Pharmacist View Video is supported by funding from AstraZeneca. AstraZeneca was not involved in the creation of the content for this Video.
An expert discusses the causes and clinical impact of hyperkalemia in chronic kidney disease and heart failure, evaluates current monitoring and treatment approaches across care settings, and highlights pharmacist-led interventions that integrate hyperkalemia management into comprehensive chronic disease care pathways.
Mitchel Rothholz, RPh, MBA, and Jeff Goad, PharmD, MPH, engage in a discussion surrounding COVID-19 vaccination, with an emphasis on boosters and strategies for initiating conversation with patients about vaccines.
The panel of experts in the management of diabetes review the role of insulin therapy and the place for biosimilars. They will review the approval process for biosimilars including the approval of the first interchangeable insulin biosimilar.
